Market data

Select a section

Hemogenyx Pharmaceuticals

(HEMO)
Sector: Pharmaceuticals & Biotechnology
0.97p
-0.24p -19.58
Last updated: 11:06:11

Company News Headlines

Date Time Headline Source
22/11/2024 12:49 Notice of Extraordinary General Meeting RNS
22/11/2024 07:00 IRB Approval for Phase I Clinical Trial RNS
11/11/2024 07:00 Institutional Investment RNS
30/10/2024 07:00 Schedule for Phase I Clinical Trial Opening RNS
02/10/2024 11:19 Strategic Investment from Prevail Partners, LLC RNS
27/09/2024 07:00 Half-year Report RNS
09/09/2024 07:00 FLT3 Assay Ready for Phase I Trials at MD Anderson RNS
02/09/2024 07:00 CDX Development Update RNS
28/08/2024 07:00 Presentation at CBD S&T Conference RNS
27/06/2024 16:39 Result of Annual General Meeting RNS
17/06/2024 07:00 Operations Update RNS
03/06/2024 07:00 Posting of Annual Report & Notice of AGM RNS
25/04/2024 07:00 Final Results RNS
28/03/2024 07:00 Total Voting Rights RNS
29/02/2024 07:00 Placing to Raise US$4.2 million RNS
16/02/2024 07:00 CBR Brain Delivery RNS
14/02/2024 07:00 CBR Intranasal Delivery RNS
09/02/2024 07:00 FDA Consents to Phase I Trials of HEMO-CAR-T RNS
02/02/2024 07:00 Approval and Issuance of U.S. Conditioning Patent RNS
16/01/2024 07:00 Submission of Complete Response to Clinical Hold RNS
08/01/2024 07:00 HEMO-CAR-T Process Qualification Run Completed RNS
28/11/2023 12:19 Placing to Raise £534,375 RNS
27/11/2023 07:00 CBR Expanded to Treatment of Cancer RNS
15/11/2023 07:00 Lentivirus Re-manufacturing Completed RNS
31/10/2023 07:00 Total Voting Rights RNS
28/09/2023 12:28 Half-year Report RNS
18/09/2023 07:00 Strategic Investment from Prevail Partners, LLC RNS
14/09/2023 07:00 Clinical Hold Lift Plan is accepted by FDA RNS
10/07/2023 07:00 Full FDA Review for HEMO-CAR-T IND RNS
30/06/2023 16:07 Result of Annual General Meeting RNS
02/06/2023 14:01 Posting of Annual Report & Notice of AGM RNS
02/06/2023 11:24 Clinical Hold on IND for HEMO-CAR-T RNS
09/05/2023 07:00 Submission of IND for HEMO-CAR-T RNS
28/04/2023 10:05 Equity Incentive Pool Increase and Option Grant RNS
28/04/2023 07:00 Final Results for the Year Ended 31 December 2022 RNS
28/02/2023 07:00 Total Voting Rights RNS
07/02/2023 14:30 Admission of Shares to Official List RNS
26/01/2023 09:05 Second Price Monitoring Extn RNS
26/01/2023 09:00 Price Monitoring Extension RNS
26/01/2023 07:00 Placing to Raise £4,056,250 RNS
16/01/2023 16:40 Second Price Monitoring Extn RNS
16/01/2023 16:35 Price Monitoring Extension RNS
13/01/2023 11:05 Second Price Monitoring Extn RNS
13/01/2023 11:00 Price Monitoring Extension RNS
12/01/2023 16:40 Second Price Monitoring Extn RNS
12/01/2023 16:35 Price Monitoring Extension RNS
12/01/2023 14:05 Second Price Monitoring Extn RNS
12/01/2023 14:00 Price Monitoring Extension RNS
10/01/2023 16:35 Price Monitoring Extension RNS
09/01/2023 09:05 Second Price Monitoring Extn RNS

Market data

Select a section